Thomas H. Moll

Adamis Pharmaceuticals Corp. manufactures and markets pharmaceutical products. It develops technology for the prevention of viral infections such as avian flu. It markets and sells prescription products for a variety of allergy, respiratory diseases, and pediatric conditions. The company was founded in June 2006 and is headquartered in San Deigo, CA.

Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany.

The North American Vascular Biology Organization provides the forum for vascular biologists who are either in the traditional basic science disciplines or studying the pathogenesis and treatment of human disease. The firm focuses on focus on development, regeneration, endothelial and smooth muscle cell biology, stem/progenitor cells, cell signaling, vascular remodeling in disease, bioengineering, vascular matrix biology, inflammation, atherosclerosis, and hypertension. The company was founded in 1994 and is headquartered in Germantown, MD.

The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation.